GENE ONLINE|News &
Opinion
Blog

Liver
Astellas Ditches Gene Therapies, with Losses Exceeding $390 Million
2022-04-25
Homology Medicines Joins Biomarin in Gene Therapy Clinical Hold
2022-02-22
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Novartis Teams Up with Alnylam to Explore Targeted Liver Therapies
2022-01-07
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Gannex Pharma Announces New Dual Targeting Drug for NASH
2022-01-05
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
R&D
NASH Drug Candidate, ASC42 Receives Fast Track Designation
2020-12-18
December 5, 2012: Scientists Discovered Over 3,000 Epigenetic Switches Control Daily Liver Cycles
2017-12-04
LATEST
Senti Biosciences to Showcase New Cell & GeneTherapy Data at AACR Annual Meeting 2025
2025-04-27
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top